Applied pharmacokinetics & pharmacodynamics : principles of therapeutic drug monitoring

著者

    • Burton, Michael E.

書誌事項

Applied pharmacokinetics & pharmacodynamics : principles of therapeutic drug monitoring

[editors], Michael E. Burton ... [et al.]

Lippincott Williams & Wilkins, c2006

4th ed

タイトル別名

Applied pharmacokinetics and pharmacodynamics

大学図書館所蔵 件 / 全17件

この図書・雑誌をさがす

注記

Rev. ed. of: Applied pharmacokinetics / edited by William E. Evans, Jerome J. Schentag, William J. Jusko. 3rd ed. c1992

Includes bibliographical references and index

HTTP:URL=http://www.loc.gov/catdir/toc/ecip0511/2005010684.html Information=Table of contents

内容説明・目次

内容説明

The definitive advanced-level clinical pharmacokinetics text is now in its Fourth Edition, with new emphasis on the relationship between pharmacokinetics and pharmacodynamics. Written by 70 leading researchers and practitioners, this book is a rigorous yet practical text on the application of pharmacokinetic methods, pharmacodynamic principles, and pharmacotherapeutic data for optimal, individualized drug therapy. This edition includes case studies that apply concepts to actual patient problems. New chapters cover tacrolimus, mycophenolic acid, sirolimus, antipsychotics, and critical evaluation of therapeutic drug monitoring methods. Other new features include more drawings and reference tables and an appendix on outcome studies with therapeutic drug monitoring.

目次

<ol> PART I: BASIC CONCEPTS AND PRINCIPLES 1 General Principles of Clinical Pharmacokinetics 3 William E. Evans Guidelines for Collection and Analysis of Pharmacokinetic Data 8 William J. Jusko Critical Evaluation of Methods for Therapeutic Drug Monitoring 30 Victor W. Armstrong and Michael Oellerich Analysis of Pharmacokinetic Data for Individualizing Drug Dosage Regimens 40 John H. Rodman, David Z. D'Argenio, and Carl C. Peck Pharmacodynamics 60 Richard L. Lalonde Influence of Protein Binding and Use of Unbound (Free) Drug Concentrations 82 Janis J. MacKichan Drug Metabolism, Transport, and the Influence of Hepatic Disease 121 Angela D.M. Kashuba, Joohyun J. Park, Adam M. Persky, and Kim L.R. Brouwer Application of Pharmacogenetic Principles to Clinical Pharmacology 165 Mark W. Linder, William E. Evans, and Howard L. McLeod Influence of Renal Function and Dialysis on Drug Disposition 187 Gary R. Matzke and Thomas J. Comstock Special Pharmacokinetic and Pharmacodynamic Considerations in Children 213 Holly D. Maples, Laura P. James, and Cindy D. Stowe Special Pharmacokinetic Considerations in the Obese 231 Robert A. Blouin and Mary H.H. Ensom Dietary Influences on Drug Disposition 242 Mary H.H. Ensom and Robert A. Blouin PART II: MONITORED DRUGS 257 Asthma Management 259 Glenn J. Whelan and Stanley J. Szefler Aminoglycosides 285 Jerome J. Schentag, Alison K. Meagher, and Roger W. Jelliffe Vancomycin 328 Pamela A. Moise-Broder Microbiologic, Clinical, and Economic Outcomes of Dual Individualized Dosing of Antimicrobial Agents 341 Joseph A. Paladino and Jerome J. Schentag Antivirals for HIV 354 Craig R. Rayner, Michael J. Dooley, and Roger L. Nation Digoxin 410 Jerome J. Schentag, Anthony J. Bang, and Jennifer L. Kozinski-Tober Clinical Pharmacokinetics of Oral Antiarrhythmic Drugs 440 Jerry L. Bauman, Harumi Takahashi, and James H. Fischer Phenytoin 463 Michael E. Winter and Thomas N. Tozer Antiepileptic Drugs 491 William R. Garnett, Gail D. Anderson, and Rebeccah J. Collins Cyclosporine 512 Atholl Johnston and David W. Holt Tacrolimus 529 Uwe Christians, Taveesak Pokaiyavanichkul, and Laurence Chan Mycophenolic Acid 563 Arthur Nawrocki, Magdalena Korecka, Sandra Solari, Juseop Kang, and Leslie M. Shaw Sirolimus 595 Barry D. Kahan and Kimberly L. Napoli Anticancer Agents 617 William P. Petros and William E. Evans Heparin UFH and LMWH 637 Keith A. Rodvold, Sharon M. Erdman, Kelly A. Sprandel, Robert J. Cipolle, and Eleanor S. Pollak Warfarin 715 Stuart T. Haines, Thomas Dowling, and R. Donald Harvey, III Nonsteroidal Anti-Inflammatory Drugs and Coxibs 752 Tilo Grosser Cyclic Antidepressants 781 C. Lindsay DeVane Lithium 798 Tawny L. Bettinger and M. Lynn Crismon Antipsychotics 813 James M. Perel and Michael W. Jann Appendix: A Critical Assessment of the Outcomes of Therapeutic Drug Monitoring 839 Mary H.H. Ensom and Michael E. Burton Index 849

「Nielsen BookData」 より

詳細情報

ページトップへ